SLS: SELLAS Life Sciences Group, Inc. Stock

by  •  • Comments Off on SLS: SELLAS Life Sciences Group, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 103.81
Enterprise Value ($M) 82.78
Book Value ($M) 15.89
Book Value / Share 0.23
Price / Book 6.53
NCAV ($M) 13.42
NCAV / Share 0.19
Price / NCAV 7.73

Profitability (mra)
Return on Invested Capital (ROIC) -1.96
Return on Assets (ROA) -5.19
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.26
Current Ratio 2.26

Balance Sheet (mrq) ($M)
Current Assets 24.04
Assets 26.50
Liabilities 10.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-08 13G/A Highbridge Capital Management Llc 9.90 537.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 528,031 2,700,314 19.55
2025-02-03 1,713,248 7,201,733 23.79
2025-01-31 1,303,159 6,648,057 19.60
2025-01-30 1,564,010 5,380,774 29.07

(click for more detail)

Similar Companies
SILO – Silo Pharma, Inc. SLGL – Sol-Gel Technologies Ltd.
SLRX – Salarius Pharmaceuticals, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc.


Financial data and stock pages provided by
Fintel.io